GANCICLOVIR/ACYCLOVIR PROPHYLAXIS REDUCES THE INCIDENCE OF CYTOMEGALOVIRUS INFECTIONS IN PANCREAS TRANSPLANT RECIPIENTS

被引：0
|
作者：
HARLAND, RC
VERNON, WB
BUNZENDAHL, H
THOMPSON, JK
LAWRENCE, C
BOLLINGER, RR
机构：
来源：
TRANSPLANTATION PROCEEDINGS | 1994年 / 26卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：432 / 433
页数：2
相关论文
共 50 条
  • [21] Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis
    Rayes, Nada
    Seehofer, Daniel
    Kahl, Andreas
    Kokott, Sophia
    Pratschke, Johann
    Frei, Ulrich
    Neuhaus, Peter
    TRANSPLANT INTERNATIONAL, 2007, 20 (11) : 974 - 981
  • [22] Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies
    Said, T
    Nampoory, MRN
    Johny, K
    Pacsa, AS
    Abraham, PM
    Nair, MP
    Abdel-Haleem, M
    Samhan, M
    Al-Mousawi, M
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (06) : 1847 - 1849
  • [23] Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients
    Canpolat, C
    Culbert, S
    Gardner, M
    Whimbey, E
    Tarrand, J
    Chan, KW
    BONE MARROW TRANSPLANTATION, 1996, 17 (04) : 589 - 593
  • [24] Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone
    Lo, A
    Stratta, RJ
    Egidi, MF
    Kizilisik, AT
    Shokouh-Amiri, MH
    Grewal, HP
    Trofe, J
    Alloway, RR
    Gaber, AO
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1796 - 1798
  • [25] High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant Recipients
    Jorgenson, Margaret R.
    Descourouez, Jillian L.
    Leverson, Glen E.
    McCreary, Erin K.
    Lucey, Michael R.
    Smith, Jeannina A.
    Redfield, Robert R.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (01) : 5 - 10
  • [26] Primary prophylaxis reduces fungal infections in transplant recipients
    不详
    Drugs & Therapy Perspectives, 2000, 15 (3) : 8 - 11
  • [27] ORAL ACYCLOVIR PROPHYLAXIS OF HERPES INFECTIONS IN RENAL-TRANSPLANT RECIPIENTS
    GRIFFIN, PJA
    COLBERT, JW
    WILLIAMSON, EPM
    FIDDIAN, AP
    HICKMOTT, E
    SELLS, RA
    SALAMAN, JR
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) : 84 - 85
  • [28] HIGH-DOSE ORAL ACYCLOVIR REDUCES THE INCIDENCE OF CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS
    MOLLISON, LC
    RICHARDS, MJ
    JOHNSON, PDR
    HAYES, K
    MUNCKHOF, WJ
    JONES, RM
    DABKOWSKI, PD
    ANGUS, PW
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03): : 721 - 724
  • [29] A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients
    Flechner, SM
    Avery, RK
    Fisher, R
    Mastroianni, BA
    Papajcik, DA
    O'Malley, KJ
    Goormastic, M
    Goldfarb, DA
    Modlin, CS
    Novick, AC
    TRANSPLANTATION, 1998, 66 (12) : 1682 - 1688
  • [30] A COMPARATIVE STUDY OF GANCICLOVIR VS. ACYCLOVIR FOR CYTOMEGALOVIRUS INFECTION TREATMENT IN RENAL TRANSPLANT RECIPIENTS
    Xue, Wujun
    Li, Yang
    Tian, Puxun
    Ding, Xiaoming
    Yan, Hang
    Feng, Xinshun
    Pan, Xiaoming
    Hou, Jun
    Xiang, Heli
    Tian, Xiaohui
    Li, Shengbin
    TRANSPLANT INTERNATIONAL, 2011, 24 : 280 - 281
12345